A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Postoperative Hemithoracic Radiation for Malignant Pleural Mesothelioma
Open Access
- 16 December 2008
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 39 (3) , 186-188
- https://doi.org/10.1093/jjco/hyn145
Abstract
A prospective multi-institutional study has been commenced in Japan to evaluate the feasibility of induction chemotherapy using pemetrexed plus cisplatin, followed by extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation in patients with resectable malignant pleural mesothelioma. The study was initiated on May 2008 and 40 patients will be recruited over 3 years. Primary endpoints are macroscopic complete resection rate by EPP and treatment-related mortality for trimodality therapy. Secondary endpoints include treatment completion rate, adverse events, response rate by chemotherapy and 2-year overall and relapse-free survival.Keywords
This publication has 9 references indexed in Scilit:
- Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II TrialJournal of Thoracic Oncology, 2006
- Macroscopic Complete Resection: The Goal of Primary Surgery in Multimodality Therapy for Pleural MesotheliomaJournal of Thoracic Oncology, 2006
- Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operationsEuropean Journal of Cardio-Thoracic Surgery, 2005
- Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2004
- Modified RECIST criteria for assessment of response in malignant pleural mesotheliomaAnnals of Oncology, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- New drugs meeting in Washington: Too demanding for clinicians?Published by Elsevier ,2000
- Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Extrapleural pneumonectomy in the treatment of malignant pleural mesotheliomaThe Annals of Thoracic Surgery, 1992